Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

An endogenous TNF-alpha antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse models.

Graziewicz MA, Tarrant TK, Buckley B, Roberts J, Fulton L, Hansen H, Ørum H, Kole R, Sazani P.

Mol Ther. 2008 Jul;16(7):1316-22. doi: 10.1038/mt.2008.85. Epub 2008 May 6.

2.

An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models.

Graziewicz MA, Tarrant TK, Buckley B, Roberts J, Fulton L, Hansen H, Ørum H, Kole R, Sazani P.

Mol Ther. 2008 Jul;16(7):1316-1322. doi: 10.1038/mt.2008.85. Epub 2016 Dec 8.

PMID:
28178484
3.

Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro.

Shimo T, Tachibana K, Saito K, Yoshida T, Tomita E, Waki R, Yamamoto T, Doi T, Inoue T, Kawakami J, Obika S.

Nucleic Acids Res. 2014 Jul;42(12):8174-87. doi: 10.1093/nar/gku512. Epub 2014 Jun 16.

4.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

5.

The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice.

Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, Kong L, Su J, Yin F, Ding AH, Zanin-Zhorov A, Dustin ML, Tao J, Craft J, Yin Z, Feng JQ, Abramson SB, Yu XP, Liu CJ.

Science. 2011 Apr 22;332(6028):478-84. doi: 10.1126/science.1199214. Epub 2011 Mar 10.

6.

Anti-arthritis effect of a novel quinazoline derivative through inhibiting production of TNF-α mediated by TNF-α converting enzyme in murine collagen-induced arthritis model.

Pu Y, Cao D, Xie C, Pei H, Li D, Tang M, Chen L.

Biochem Biophys Res Commun. 2015 Jul 10;462(4):288-93. doi: 10.1016/j.bbrc.2015.04.111. Epub 2015 Apr 30.

PMID:
25935488
7.

Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

McCann FE, Perocheau DP, Ruspi G, Blazek K, Davies ML, Feldmann M, Dean JL, Stoop AA, Williams RO.

Arthritis Rheumatol. 2014 Oct;66(10):2728-38. doi: 10.1002/art.38755.

8.

Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.

Kan F, Ren G, Guo M, Qi J, Zhang Y, Han Y, Zhang Y, Li D.

Curr Pharm Biotechnol. 2014;14(12):1048-61.

PMID:
24433504
9.
10.

Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report.

Ventura E, Balza E, Borsi L, Tutolo G, Carnemolla B, Castellani P, Zardi L.

BMC Biotechnol. 2011 Nov 10;11:104. doi: 10.1186/1472-6750-11-104.

11.

Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade.

Gompels LL, Malik NM, Madden L, Jin P, Feldmann M, Shepard HM, Paleolog EM.

Arthritis Res Ther. 2011;13(5):R161. doi: 10.1186/ar3480. Epub 2011 Oct 7.

12.

Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity.

Abe Y, Yoshikawa T, Kamada H, Shibata H, Nomura T, Minowa K, Kayamuro H, Katayama K, Miyoshi H, Mukai Y, Yoshioka Y, Nakagawa S, Tsunoda S, Tsutsumi Y.

J Immunol Methods. 2008 Jun 1;335(1-2):71-8. doi: 10.1016/j.jim.2008.02.019. Epub 2008 Mar 26.

PMID:
18417150
13.
14.

Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages.

Salmeri FM, Laganà AS, Sofo V, Triolo O, Sturlese E, Retto G, Pizzo A, D'Ascola A, Campo S.

Reprod Sci. 2015 Feb;22(2):165-72. doi: 10.1177/1933719114536472. Epub 2014 May 20.

15.

Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model.

Constantin CE, Mair N, Sailer CA, Andratsch M, Xu ZZ, Blumer MJ, Scherbakov N, Davis JB, Bluethmann H, Ji RR, Kress M.

J Neurosci. 2008 May 7;28(19):5072-81. doi: 10.1523/JNEUROSCI.4476-07.2008.

16.

Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning.

Abe Y, Yoshikawa T, Inoue M, Nomura T, Furuya T, Yamashita T, Nagano K, Nabeshi H, Yoshioka Y, Mukai Y, Nakagawa S, Kamada H, Tsutsumi Y, Tsunoda S.

Biomaterials. 2011 Aug;32(23):5498-504. doi: 10.1016/j.biomaterials.2011.04.018. Epub 2011 May 5.

PMID:
21546081
17.

The tumor necrosis factor type 2 receptor plays a protective role in tumor necrosis factor-α-induced bone resorption lacunae on mouse calvariae.

Nagano K, Alles N, Mian AH, Shimoda A, Morimoto N, Tamura Y, Shimokawa H, Akiyoshi K, Ohya K, Aoki K.

J Bone Miner Metab. 2011 Nov;29(6):671-81. doi: 10.1007/s00774-011-0270-z. Epub 2011 Jun 1.

PMID:
21626455
18.

TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.

Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME.

Bone. 2004 Nov;35(5):1200-7.

PMID:
15542046
19.
20.

Supplemental Content

Support Center